Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness
Background: Human papillomavirus (HPV) vaccination for young women up to age 26 is highly cost-effective and has been implemented in 65 countries globally. We investigate the cost-effectiveness for HPV vaccination program in older women (age > 26 years), heterosexual men and men who have sex with me...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2018-12-01
|
| Collection: | Human Vaccines & Immunotherapeutics |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.1080/21645515.2018.1496878 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|